nodes	percent_of_prediction	percent_of_DWPC	metapath
Docetaxel—head and neck cancer—ocular cancer	0.26	0.371	CtDrD
Docetaxel—melanoma—ocular cancer	0.228	0.326	CtDrD
Docetaxel—skin cancer—ocular cancer	0.212	0.303	CtDrD
Docetaxel—ABCC1—Dactinomycin—ocular cancer	0.0695	0.35	CbGbCtD
Docetaxel—ABCG2—Dactinomycin—ocular cancer	0.0465	0.234	CbGbCtD
Docetaxel—ABCC2—Carboplatin—ocular cancer	0.0346	0.174	CbGbCtD
Docetaxel—ABCG2—Carboplatin—ocular cancer	0.0313	0.157	CbGbCtD
Docetaxel—ABCB1—Dactinomycin—ocular cancer	0.0168	0.0844	CbGbCtD
Docetaxel—Radiation recall reaction (dermatologic)—Dactinomycin—ocular cancer	0.0027	0.0984	CcSEcCtD
Docetaxel—Neutropenic sepsis—Dactinomycin—ocular cancer	0.00256	0.0932	CcSEcCtD
Docetaxel—Recall phenomenon—Dactinomycin—ocular cancer	0.00256	0.0932	CcSEcCtD
Docetaxel—Extravasation—Carboplatin—ocular cancer	0.00137	0.0499	CcSEcCtD
Docetaxel—Multi-organ failure—Dactinomycin—ocular cancer	0.00136	0.0496	CcSEcCtD
Docetaxel—Phlebitis—Carboplatin—ocular cancer	0.00101	0.0367	CcSEcCtD
Docetaxel—Ascites—Dactinomycin—ocular cancer	0.000975	0.0356	CcSEcCtD
Docetaxel—Raised liver function tests—Dactinomycin—ocular cancer	0.00096	0.035	CcSEcCtD
Docetaxel—Myelosuppression—Dactinomycin—ocular cancer	0.000945	0.0345	CcSEcCtD
Docetaxel—Febrile neutropenia—Dactinomycin—ocular cancer	0.000737	0.0269	CcSEcCtD
Docetaxel—Eruption—Dactinomycin—ocular cancer	0.000721	0.0263	CcSEcCtD
Docetaxel—Hepatotoxicity—Dactinomycin—ocular cancer	0.000574	0.0209	CcSEcCtD
Docetaxel—Necrosis—Dactinomycin—ocular cancer	0.000565	0.0206	CcSEcCtD
Docetaxel—Extravasation—Dactinomycin—ocular cancer	0.000508	0.0185	CcSEcCtD
Docetaxel—Infection—Carboplatin—ocular cancer	0.000423	0.0154	CcSEcCtD
Docetaxel—Oesophagitis—Dactinomycin—ocular cancer	0.000405	0.0148	CcSEcCtD
Docetaxel—Sepsis—Dactinomycin—ocular cancer	0.000385	0.014	CcSEcCtD
Docetaxel—MAPT—retina—ocular cancer	0.000382	0.0865	CbGeAlD
Docetaxel—Phlebitis—Dactinomycin—ocular cancer	0.000373	0.0136	CcSEcCtD
Docetaxel—Pain—Carboplatin—ocular cancer	0.000364	0.0133	CcSEcCtD
Docetaxel—Hepatic failure—Dactinomycin—ocular cancer	0.000358	0.0131	CcSEcCtD
Docetaxel—Body temperature increased—Carboplatin—ocular cancer	0.000337	0.0123	CcSEcCtD
Docetaxel—Lethargy—Dactinomycin—ocular cancer	0.000328	0.012	CcSEcCtD
Docetaxel—MAP4—eye—ocular cancer	0.000303	0.0687	CbGeAlD
Docetaxel—MAP4—retina—ocular cancer	0.0003	0.068	CbGeAlD
Docetaxel—Liver function test abnormal—Dactinomycin—ocular cancer	0.000297	0.0108	CcSEcCtD
Docetaxel—Aspartate aminotransferase increased—Dactinomycin—ocular cancer	0.00029	0.0106	CcSEcCtD
Docetaxel—Toxic epidermal necrolysis—Dactinomycin—ocular cancer	0.00029	0.0106	CcSEcCtD
Docetaxel—Dysphagia—Dactinomycin—ocular cancer	0.000278	0.0101	CcSEcCtD
Docetaxel—Pancytopenia—Dactinomycin—ocular cancer	0.000264	0.00963	CcSEcCtD
Docetaxel—Neutropenia—Dactinomycin—ocular cancer	0.00026	0.00948	CcSEcCtD
Docetaxel—BCL2—epithelium—ocular cancer	0.000252	0.0571	CbGeAlD
Docetaxel—Pneumonia—Dactinomycin—ocular cancer	0.000249	0.00909	CcSEcCtD
Docetaxel—Stevens-Johnson syndrome—Dactinomycin—ocular cancer	0.000246	0.00896	CcSEcCtD
Docetaxel—Stomatitis—Dactinomycin—ocular cancer	0.000242	0.00881	CcSEcCtD
Docetaxel—MAP2—eye—ocular cancer	0.000239	0.0541	CbGeAlD
Docetaxel—MAP2—retina—ocular cancer	0.000236	0.0536	CbGeAlD
Docetaxel—Agranulocytosis—Dactinomycin—ocular cancer	0.000231	0.00843	CcSEcCtD
Docetaxel—Hepatitis—Dactinomycin—ocular cancer	0.000223	0.00811	CcSEcCtD
Docetaxel—Pharyngitis—Dactinomycin—ocular cancer	0.000221	0.00805	CcSEcCtD
Docetaxel—TUBB3—lymphoid tissue—ocular cancer	0.000213	0.0484	CbGeAlD
Docetaxel—MAP4—lymphoid tissue—ocular cancer	0.000213	0.0484	CbGeAlD
Docetaxel—Erythema multiforme—Dactinomycin—ocular cancer	0.00021	0.00767	CcSEcCtD
Docetaxel—Flushing—Dactinomycin—ocular cancer	0.000207	0.00753	CcSEcCtD
Docetaxel—Chills—Dactinomycin—ocular cancer	0.0002	0.00728	CcSEcCtD
Docetaxel—Alopecia—Dactinomycin—ocular cancer	0.000197	0.00717	CcSEcCtD
Docetaxel—BCL2—lymphoid tissue—ocular cancer	0.000194	0.044	CbGeAlD
Docetaxel—Erythema—Dactinomycin—ocular cancer	0.000194	0.00706	CcSEcCtD
Docetaxel—TUBB4A—eye—ocular cancer	0.000184	0.0418	CbGeAlD
Docetaxel—TUBB4A—retina—ocular cancer	0.000183	0.0414	CbGeAlD
Docetaxel—Anaemia—Dactinomycin—ocular cancer	0.000179	0.00653	CcSEcCtD
Docetaxel—TUBB2B—eye—ocular cancer	0.000178	0.0404	CbGeAlD
Docetaxel—TUBB2B—retina—ocular cancer	0.000177	0.04	CbGeAlD
Docetaxel—Leukopenia—Dactinomycin—ocular cancer	0.000173	0.00632	CcSEcCtD
Docetaxel—TUBB2A—eye—ocular cancer	0.000168	0.038	CbGeAlD
Docetaxel—Myalgia—Dactinomycin—ocular cancer	0.000165	0.00601	CcSEcCtD
Docetaxel—Oedema—Dactinomycin—ocular cancer	0.000158	0.00576	CcSEcCtD
Docetaxel—Infection—Dactinomycin—ocular cancer	0.000157	0.00573	CcSEcCtD
Docetaxel—Thrombocytopenia—Dactinomycin—ocular cancer	0.000155	0.00564	CcSEcCtD
Docetaxel—TUBB6—epithelium—ocular cancer	0.000151	0.0343	CbGeAlD
Docetaxel—Anorexia—Dactinomycin—ocular cancer	0.000151	0.00549	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Dactinomycin—ocular cancer	0.000144	0.00525	CcSEcCtD
Docetaxel—TUBB4B—eye—ocular cancer	0.000144	0.0326	CbGeAlD
Docetaxel—TUBB4B—retina—ocular cancer	0.000143	0.0323	CbGeAlD
Docetaxel—Decreased appetite—Dactinomycin—ocular cancer	0.000137	0.00501	CcSEcCtD
Docetaxel—Fatigue—Dactinomycin—ocular cancer	0.000136	0.00497	CcSEcCtD
Docetaxel—Pain—Dactinomycin—ocular cancer	0.000135	0.00493	CcSEcCtD
Docetaxel—Feeling abnormal—Dactinomycin—ocular cancer	0.00013	0.00475	CcSEcCtD
Docetaxel—TUBB4A—lymphoid tissue—ocular cancer	0.00013	0.0294	CbGeAlD
Docetaxel—Gastrointestinal pain—Dactinomycin—ocular cancer	0.000129	0.00471	CcSEcCtD
Docetaxel—Body temperature increased—Dactinomycin—ocular cancer	0.000125	0.00456	CcSEcCtD
Docetaxel—Abdominal pain—Dactinomycin—ocular cancer	0.000125	0.00456	CcSEcCtD
Docetaxel—TUBB6—lymphoid tissue—ocular cancer	0.000117	0.0264	CbGeAlD
Docetaxel—Hypersensitivity—Dactinomycin—ocular cancer	0.000117	0.00425	CcSEcCtD
Docetaxel—CYP1B1—eye—ocular cancer	0.000114	0.0258	CbGeAlD
Docetaxel—Asthenia—Dactinomycin—ocular cancer	0.000113	0.00414	CcSEcCtD
Docetaxel—Diarrhoea—Dactinomycin—ocular cancer	0.000108	0.00394	CcSEcCtD
Docetaxel—ABCC10—lymphoid tissue—ocular cancer	0.000102	0.0231	CbGeAlD
Docetaxel—TUBB4B—lymphoid tissue—ocular cancer	0.000101	0.023	CbGeAlD
Docetaxel—Vomiting—Dactinomycin—ocular cancer	0.000101	0.00367	CcSEcCtD
Docetaxel—Rash—Dactinomycin—ocular cancer	9.97e-05	0.00363	CcSEcCtD
Docetaxel—Nausea—Dactinomycin—ocular cancer	9.39e-05	0.00342	CcSEcCtD
Docetaxel—CYP1B1—lymphoid tissue—ocular cancer	8.03e-05	0.0182	CbGeAlD
Docetaxel—ABCB1—retina—ocular cancer	4.15e-05	0.00939	CbGeAlD
Docetaxel—ABCB1—epithelium—ocular cancer	3.83e-05	0.00867	CbGeAlD
Docetaxel—ABCB1—lymphoid tissue—ocular cancer	2.95e-05	0.00668	CbGeAlD
Docetaxel—KIF11—Immune System—HRAS—ocular cancer	2.06e-05	0.000299	CbGpPWpGaD
Docetaxel—TUBB—Cell Cycle, Mitotic—EP300—ocular cancer	2.05e-05	0.000297	CbGpPWpGaD
Docetaxel—EGFR—Spinal Cord Injury—TP53—ocular cancer	2.03e-05	0.000295	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle—RB1—ocular cancer	2.03e-05	0.000295	CbGpPWpGaD
Docetaxel—EGFR—Integrated Breast Cancer Pathway—MYC—ocular cancer	2.03e-05	0.000295	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	2.03e-05	0.000295	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	2.01e-05	0.000292	CbGpPWpGaD
Docetaxel—EGFR—B Cell Activation—CDKN1A—ocular cancer	2e-05	0.00029	CbGpPWpGaD
Docetaxel—TUBB—Cell Cycle—CCND1—ocular cancer	1.99e-05	0.000289	CbGpPWpGaD
Docetaxel—EGFR—PI-3K cascade—AKT1—ocular cancer	1.99e-05	0.000289	CbGpPWpGaD
Docetaxel—BCL2—Focal Adhesion—AKT1—ocular cancer	1.98e-05	0.000288	CbGpPWpGaD
Docetaxel—BCL2—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	1.97e-05	0.000287	CbGpPWpGaD
Docetaxel—ABCC1—Disease—TFDP1—ocular cancer	1.96e-05	0.000285	CbGpPWpGaD
Docetaxel—EGFR—PI3K/AKT activation—AKT1—ocular cancer	1.94e-05	0.000282	CbGpPWpGaD
Docetaxel—TUBB4A—Cell Cycle, Mitotic—CDKN1B—ocular cancer	1.93e-05	0.000281	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	1.93e-05	0.00028	CbGpPWpGaD
Docetaxel—EGFR—GAB1 signalosome—AKT1—ocular cancer	1.93e-05	0.00028	CbGpPWpGaD
Docetaxel—TUBB—Cell Cycle—CDKN1A—ocular cancer	1.92e-05	0.000279	CbGpPWpGaD
Docetaxel—GHRHR—Signaling by GPCR—HRAS—ocular cancer	1.91e-05	0.000278	CbGpPWpGaD
Docetaxel—EGFR—NGF signalling via TRKA from the plasma membrane—CDKN1A—ocular cancer	1.91e-05	0.000277	CbGpPWpGaD
Docetaxel—TUBB4A—Cell Cycle—MDM2—ocular cancer	1.89e-05	0.000275	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—SAG—ocular cancer	1.89e-05	0.000275	CbGpPWpGaD
Docetaxel—EGFR—ErbB1 downstream signaling—AKT1—ocular cancer	1.88e-05	0.000273	CbGpPWpGaD
Docetaxel—EGFR—Role of LAT2/NTAL/LAB on calcium mobilization—AKT1—ocular cancer	1.88e-05	0.000273	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—CDKN1B—ocular cancer	1.88e-05	0.000273	CbGpPWpGaD
Docetaxel—EGFR—MAPK Signaling Pathway—MYC—ocular cancer	1.86e-05	0.000271	CbGpPWpGaD
Docetaxel—GHRHR—GPCR downstream signaling—AKT1—ocular cancer	1.86e-05	0.00027	CbGpPWpGaD
Docetaxel—EGFR—MAPK Signaling Pathway—TGFB1—ocular cancer	1.86e-05	0.00027	CbGpPWpGaD
Docetaxel—EGFR—Disease—TFDP1—ocular cancer	1.85e-05	0.000269	CbGpPWpGaD
Docetaxel—TUBB4A—Cell Cycle, Mitotic—CCND1—ocular cancer	1.84e-05	0.000268	CbGpPWpGaD
Docetaxel—TUBB—Cell Cycle—EP300—ocular cancer	1.83e-05	0.000266	CbGpPWpGaD
Docetaxel—KIF11—Immune System—AKT1—ocular cancer	1.82e-05	0.000264	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—CCND1—ocular cancer	1.8e-05	0.000261	CbGpPWpGaD
Docetaxel—TUBB—Cell Cycle, Mitotic—MYC—ocular cancer	1.78e-05	0.000259	CbGpPWpGaD
Docetaxel—TUBB4A—Cell Cycle, Mitotic—CDKN1A—ocular cancer	1.78e-05	0.000259	CbGpPWpGaD
Docetaxel—EGFR—Direct p53 effectors—TP53—ocular cancer	1.77e-05	0.000257	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle, Mitotic—CDKN1B—ocular cancer	1.77e-05	0.000257	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—MDM2—ocular cancer	1.74e-05	0.000253	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—CDKN1A—ocular cancer	1.74e-05	0.000252	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	1.73e-05	0.000252	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle—MDM2—ocular cancer	1.73e-05	0.000251	CbGpPWpGaD
Docetaxel—TUBB4A—Cell Cycle—CDKN1B—ocular cancer	1.73e-05	0.000251	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PSPH—ocular cancer	1.72e-05	0.00025	CbGpPWpGaD
Docetaxel—ABCB1—Allograft Rejection—TGFB1—ocular cancer	1.72e-05	0.000249	CbGpPWpGaD
Docetaxel—TUBB4A—Cell Cycle, Mitotic—EP300—ocular cancer	1.7e-05	0.000246	CbGpPWpGaD
Docetaxel—GHRHR—Signaling by GPCR—AKT1—ocular cancer	1.69e-05	0.000245	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle, Mitotic—CCND1—ocular cancer	1.69e-05	0.000245	CbGpPWpGaD
Docetaxel—EGFR—Signaling by SCF-KIT—HRAS—ocular cancer	1.68e-05	0.000245	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	1.68e-05	0.000244	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—MDM2—ocular cancer	1.68e-05	0.000244	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	1.68e-05	0.000244	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—E2F5—ocular cancer	1.67e-05	0.000243	CbGpPWpGaD
Docetaxel—EGFR—Integrated Breast Cancer Pathway—TP53—ocular cancer	1.67e-05	0.000242	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—EP300—ocular cancer	1.65e-05	0.00024	CbGpPWpGaD
Docetaxel—TUBB4A—Cell Cycle—CCND1—ocular cancer	1.65e-05	0.000239	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—E2F4—ocular cancer	1.64e-05	0.000238	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	1.64e-05	0.000238	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle, Mitotic—CDKN1A—ocular cancer	1.63e-05	0.000237	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—GNA11—ocular cancer	1.61e-05	0.000234	CbGpPWpGaD
Docetaxel—EGFR—Downstream signaling of activated FGFR—HRAS—ocular cancer	1.61e-05	0.000234	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—RBL1—ocular cancer	1.61e-05	0.000234	CbGpPWpGaD
Docetaxel—TUBB—Cell Cycle—MYC—ocular cancer	1.6e-05	0.000232	CbGpPWpGaD
Docetaxel—TUBB4A—Cell Cycle—CDKN1A—ocular cancer	1.59e-05	0.000232	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—CDKN1B—ocular cancer	1.59e-05	0.000231	CbGpPWpGaD
Docetaxel—EGFR—Signaling by ERBB4—HRAS—ocular cancer	1.59e-05	0.00023	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle—CDKN1B—ocular cancer	1.58e-05	0.00023	CbGpPWpGaD
Docetaxel—ABCC1—Disease—MAML2—ocular cancer	1.56e-05	0.000227	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle, Mitotic—EP300—ocular cancer	1.55e-05	0.000225	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—CDKN1B—ocular cancer	1.54e-05	0.000223	CbGpPWpGaD
Docetaxel—EGFR—MAPK Signaling Pathway—TP53—ocular cancer	1.53e-05	0.000222	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—GNA11—ocular cancer	1.52e-05	0.000221	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—CDK4—ocular cancer	1.52e-05	0.000221	CbGpPWpGaD
Docetaxel—TUBB4A—Cell Cycle—EP300—ocular cancer	1.52e-05	0.00022	CbGpPWpGaD
Docetaxel—EGFR—Downstream signal transduction—HRAS—ocular cancer	1.51e-05	0.00022	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle—CCND1—ocular cancer	1.51e-05	0.000219	CbGpPWpGaD
Docetaxel—EGFR—EGF/EGFR Signaling Pathway—HRAS—ocular cancer	1.51e-05	0.000219	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR—HRAS—ocular cancer	1.51e-05	0.000219	CbGpPWpGaD
Docetaxel—EGFR—Signaling by ERBB2—HRAS—ocular cancer	1.5e-05	0.000218	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—GNAQ—ocular cancer	1.5e-05	0.000218	CbGpPWpGaD
Docetaxel—EGFR—DAP12 signaling—HRAS—ocular cancer	1.49e-05	0.000217	CbGpPWpGaD
Docetaxel—EGFR—Signaling by SCF-KIT—AKT1—ocular cancer	1.49e-05	0.000216	CbGpPWpGaD
Docetaxel—TUBB4A—Cell Cycle, Mitotic—MYC—ocular cancer	1.48e-05	0.000215	CbGpPWpGaD
Docetaxel—EGFR—Downstream signaling events of B Cell Receptor (BCR)—HRAS—ocular cancer	1.47e-05	0.000214	CbGpPWpGaD
Docetaxel—EGFR—Disease—MAML2—ocular cancer	1.47e-05	0.000214	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—CDKN1A—ocular cancer	1.47e-05	0.000213	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle—CDKN1A—ocular cancer	1.46e-05	0.000212	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—MYC—ocular cancer	1.44e-05	0.000209	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—TGFB1—ocular cancer	1.44e-05	0.000209	CbGpPWpGaD
Docetaxel—EGFR—Downstream signaling of activated FGFR—AKT1—ocular cancer	1.42e-05	0.000207	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—CDKN1A—ocular cancer	1.42e-05	0.000206	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—GNAQ—ocular cancer	1.41e-05	0.000205	CbGpPWpGaD
Docetaxel—EGFR—Integrated Breast Cancer Pathway—AKT1—ocular cancer	1.41e-05	0.000204	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR in disease—HRAS—ocular cancer	1.4e-05	0.000204	CbGpPWpGaD
Docetaxel—EGFR—Fc epsilon receptor (FCERI) signaling—HRAS—ocular cancer	1.4e-05	0.000204	CbGpPWpGaD
Docetaxel—EGFR—DAP12 interactions—HRAS—ocular cancer	1.4e-05	0.000204	CbGpPWpGaD
Docetaxel—EGFR—Signaling by ERBB4—AKT1—ocular cancer	1.4e-05	0.000203	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—E2F3—ocular cancer	1.39e-05	0.000202	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR—HRAS—ocular cancer	1.39e-05	0.000202	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle—EP300—ocular cancer	1.39e-05	0.000202	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	1.38e-05	0.000201	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR in Cancer—HRAS—ocular cancer	1.38e-05	0.0002	CbGpPWpGaD
Docetaxel—ABCB1—HIF-1-alpha transcription factor network—AKT1—ocular cancer	1.38e-05	0.0002	CbGpPWpGaD
Docetaxel—EGFR—Signaling by PDGF—HRAS—ocular cancer	1.37e-05	0.000199	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle, Mitotic—MYC—ocular cancer	1.35e-05	0.000196	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—EP300—ocular cancer	1.35e-05	0.000196	CbGpPWpGaD
Docetaxel—EGFR—Downstream signal transduction—AKT1—ocular cancer	1.34e-05	0.000194	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR—AKT1—ocular cancer	1.33e-05	0.000193	CbGpPWpGaD
Docetaxel—EGFR—EGF/EGFR Signaling Pathway—AKT1—ocular cancer	1.33e-05	0.000193	CbGpPWpGaD
Docetaxel—EGFR—Focal Adhesion—HRAS—ocular cancer	1.33e-05	0.000193	CbGpPWpGaD
Docetaxel—EGFR—Signaling by ERBB2—AKT1—ocular cancer	1.32e-05	0.000192	CbGpPWpGaD
Docetaxel—TUBB4A—Cell Cycle—MYC—ocular cancer	1.32e-05	0.000192	CbGpPWpGaD
Docetaxel—EGFR—DAP12 signaling—AKT1—ocular cancer	1.32e-05	0.000191	CbGpPWpGaD
Docetaxel—TUBB—Cell Cycle—TP53—ocular cancer	1.31e-05	0.00019	CbGpPWpGaD
Docetaxel—EGFR—B Cell Activation—HRAS—ocular cancer	1.3e-05	0.000189	CbGpPWpGaD
Docetaxel—EGFR—Downstream signaling events of B Cell Receptor (BCR)—AKT1—ocular cancer	1.3e-05	0.000189	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TFDP1—ocular cancer	1.3e-05	0.000188	CbGpPWpGaD
Docetaxel—EGFR—MAPK Signaling Pathway—AKT1—ocular cancer	1.29e-05	0.000188	CbGpPWpGaD
Docetaxel—EGFR—NGF signalling via TRKA from the plasma membrane—HRAS—ocular cancer	1.24e-05	0.000181	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR in disease—AKT1—ocular cancer	1.24e-05	0.00018	CbGpPWpGaD
Docetaxel—EGFR—Fc epsilon receptor (FCERI) signaling—AKT1—ocular cancer	1.24e-05	0.00018	CbGpPWpGaD
Docetaxel—EGFR—DAP12 interactions—AKT1—ocular cancer	1.24e-05	0.00018	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR—AKT1—ocular cancer	1.23e-05	0.000178	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR in Cancer—AKT1—ocular cancer	1.22e-05	0.000177	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	1.22e-05	0.000176	CbGpPWpGaD
Docetaxel—EGFR—Signaling by PDGF—AKT1—ocular cancer	1.21e-05	0.000176	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism of lipids and lipoproteins—EP300—ocular cancer	1.21e-05	0.000176	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle—MYC—ocular cancer	1.21e-05	0.000176	CbGpPWpGaD
Docetaxel—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—ocular cancer	1.2e-05	0.000175	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—TP53—ocular cancer	1.18e-05	0.000172	CbGpPWpGaD
Docetaxel—EGFR—Focal Adhesion—AKT1—ocular cancer	1.17e-05	0.00017	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	1.17e-05	0.000169	CbGpPWpGaD
Docetaxel—EGFR—B Cell Activation—AKT1—ocular cancer	1.15e-05	0.000167	CbGpPWpGaD
Docetaxel—ABCC1—Disease—HDAC1—ocular cancer	1.14e-05	0.000166	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—GNA11—ocular cancer	1.14e-05	0.000166	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—HRAS—ocular cancer	1.13e-05	0.000164	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	1.11e-05	0.000161	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—GNA11—ocular cancer	1.1e-05	0.00016	CbGpPWpGaD
Docetaxel—EGFR—NGF signalling via TRKA from the plasma membrane—AKT1—ocular cancer	1.1e-05	0.000159	CbGpPWpGaD
Docetaxel—TUBB4A—Cell Cycle—TP53—ocular cancer	1.09e-05	0.000158	CbGpPWpGaD
Docetaxel—NR1I2—Gene Expression—MYC—ocular cancer	1.08e-05	0.000157	CbGpPWpGaD
Docetaxel—EGFR—Disease—HDAC1—ocular cancer	1.08e-05	0.000156	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PSPH—ocular cancer	1.06e-05	0.000154	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—GNAQ—ocular cancer	1.06e-05	0.000154	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	1.06e-05	0.000154	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MAML2—ocular cancer	1.03e-05	0.00015	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—GNAQ—ocular cancer	1.03e-05	0.000149	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	1.02e-05	0.000149	CbGpPWpGaD
Docetaxel—ABCC1—Disease—CDKN2B—ocular cancer	1.02e-05	0.000148	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—GNA11—ocular cancer	1e-05	0.000146	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—AKT1—ocular cancer	9.99e-06	0.000145	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—GNA11—ocular cancer	9.94e-06	0.000144	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—MDM2—ocular cancer	9.94e-06	0.000144	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle—TP53—ocular cancer	9.93e-06	0.000144	CbGpPWpGaD
Docetaxel—BCL2—Immune System—MDM2—ocular cancer	9.8e-06	0.000142	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	9.74e-06	0.000141	CbGpPWpGaD
Docetaxel—EGFR—Disease—CDKN2B—ocular cancer	9.64e-06	0.00014	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—HRAS—ocular cancer	9.57e-06	0.000139	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—MDM2—ocular cancer	9.55e-06	0.000139	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—GNAQ—ocular cancer	9.33e-06	0.000135	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—GNAQ—ocular cancer	9.24e-06	0.000134	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—HRAS—ocular cancer	9.23e-06	0.000134	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—CDKN1B—ocular cancer	9.08e-06	0.000132	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—EP300—ocular cancer	9.03e-06	0.000131	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—GNA11—ocular cancer	8.99e-06	0.00013	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CDKN1B—ocular cancer	8.94e-06	0.00013	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—CDKN1B—ocular cancer	8.72e-06	0.000127	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—HRAS—ocular cancer	8.66e-06	0.000126	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism of lipids and lipoproteins—EP300—ocular cancer	8.55e-06	0.000124	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	8.49e-06	0.000123	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	8.47e-06	0.000123	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—AKT1—ocular cancer	8.45e-06	0.000123	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—CDKN1A—ocular cancer	8.38e-06	0.000122	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—GNAQ—ocular cancer	8.35e-06	0.000121	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism of lipids and lipoproteins—EP300—ocular cancer	8.27e-06	0.00012	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CDKN1A—ocular cancer	8.25e-06	0.00012	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—AKT1—ocular cancer	8.15e-06	0.000118	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—CDKN1A—ocular cancer	8.05e-06	0.000117	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—EP300—ocular cancer	7.97e-06	0.000116	CbGpPWpGaD
Docetaxel—BCL2—Immune System—EP300—ocular cancer	7.85e-06	0.000114	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—TGFB1—ocular cancer	7.85e-06	0.000114	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—HDAC1—ocular cancer	7.53e-06	0.000109	CbGpPWpGaD
Docetaxel—NR1I2—Gene Expression—AKT1—ocular cancer	7.5e-06	0.000109	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—GNA11—ocular cancer	7.19e-06	0.000104	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	6.97e-06	0.000101	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CDKN2B—ocular cancer	6.75e-06	9.8e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—GNAQ—ocular cancer	6.68e-06	9.7e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—E2F1—ocular cancer	6.2e-06	9e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—HRAS—ocular cancer	6.18e-06	8.97e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	5.89e-06	8.55e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—MDM2—ocular cancer	5.79e-06	8.41e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—MDM2—ocular cancer	5.67e-06	8.24e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—HRAS—ocular cancer	5.46e-06	7.92e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—AKT1—ocular cancer	5.45e-06	7.92e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—GNA11—ocular cancer	5.42e-06	7.88e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—EP300—ocular cancer	5.39e-06	7.82e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—HRAS—ocular cancer	5.38e-06	7.8e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—MDM2—ocular cancer	5.35e-06	7.76e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CDKN1B—ocular cancer	5.29e-06	7.68e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—HRAS—ocular cancer	5.24e-06	7.61e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—CDKN1B—ocular cancer	5.18e-06	7.52e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—GNAQ—ocular cancer	5.04e-06	7.32e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—CDKN1B—ocular cancer	4.88e-06	7.09e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CDKN1A—ocular cancer	4.88e-06	7.09e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—AKT1—ocular cancer	4.82e-06	7e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—CDKN1A—ocular cancer	4.78e-06	6.94e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—AKT1—ocular cancer	4.75e-06	6.89e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—EP300—ocular cancer	4.64e-06	6.74e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—AKT1—ocular cancer	4.63e-06	6.72e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—EP300—ocular cancer	4.55e-06	6.6e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—CDKN1A—ocular cancer	4.51e-06	6.54e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—EP300—ocular cancer	4.29e-06	6.22e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—MYC—ocular cancer	3.96e-06	5.75e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—TGFB1—ocular cancer	3.95e-06	5.74e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—EP300—ocular cancer	3.81e-06	5.53e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MDM2—ocular cancer	3.74e-06	5.44e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—MYC—ocular cancer	3.74e-06	5.42e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—TGFB1—ocular cancer	3.73e-06	5.41e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—EP300—ocular cancer	3.68e-06	5.35e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—HRAS—ocular cancer	3.48e-06	5.05e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CDKN1B—ocular cancer	3.42e-06	4.96e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—EP300—ocular cancer	3.35e-06	4.87e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GNA11—ocular cancer	3.34e-06	4.85e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—EP300—ocular cancer	3.32e-06	4.82e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CCND1—ocular cancer	3.26e-06	4.74e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—AKT1—ocular cancer	3.26e-06	4.73e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—HRAS—ocular cancer	3.18e-06	4.61e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CDKN1A—ocular cancer	3.16e-06	4.58e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—HRAS—ocular cancer	3.11e-06	4.52e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GNAQ—ocular cancer	3.11e-06	4.51e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—AKT1—ocular cancer	3.07e-06	4.46e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—EP300—ocular cancer	3e-06	4.36e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—HRAS—ocular cancer	2.93e-06	4.26e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—AKT1—ocular cancer	2.81e-06	4.07e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—AKT1—ocular cancer	2.75e-06	3.99e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MYC—ocular cancer	2.62e-06	3.8e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TGFB1—ocular cancer	2.61e-06	3.79e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—AKT1—ocular cancer	2.59e-06	3.76e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—EP300—ocular cancer	2.4e-06	3.49e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—AKT1—ocular cancer	2.3e-06	3.34e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—AKT1—ocular cancer	2.23e-06	3.23e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TP53—ocular cancer	2.15e-06	3.12e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—HRAS—ocular cancer	2.05e-06	2.98e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—AKT1—ocular cancer	2.03e-06	2.94e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—AKT1—ocular cancer	2.01e-06	2.92e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—AKT1—ocular cancer	1.81e-06	2.63e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—EP300—ocular cancer	1.81e-06	2.63e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—AKT1—ocular cancer	1.45e-06	2.11e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—EP300—ocular cancer	1.12e-06	1.62e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—AKT1—ocular cancer	1.1e-06	1.59e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—AKT1—ocular cancer	6.75e-07	9.8e-06	CbGpPWpGaD
